KIES PETER

Average Profitability
7.37%
Insider Buys Quantity
5
Insider Buys Sum
$83,102.40
Insider Sells Quantity
10
Insider Sells Sum
$3.03M

Insider Activity of KIES PETER

The largest purchase of all time was on 2014-10-09 and amounted to 3960 shares of Inovio Pharmaceuticals, Inc. for $39,996.

The largest sale of all time was on 2020-06-30 and amounted to 35000 shares of Inovio Pharmaceuticals, Inc. for $927,500.

Biography of KIES PETER

No biography is available at this moment.

2021-06-09SaleInovio Pharmaceuticals, Inc.
INO
CFO
33,750
0.0161%
$10.01$337,838-37.39%
2021-06-03SaleInovio Pharmaceuticals, Inc.
INO
CFO
10,000
0.0049%
$8.03$80,300-17.24%
2021-04-21SaleInovio Pharmaceuticals, Inc.
INO
CFO
10,000
0.0044%
$8.52$85,200-24.45%
2021-01-15SaleInovio Pharmaceuticals, Inc.
INO
CFO
30,000
0.0154%
$10.02$300,558-15.27%
2020-12-15SaleInovio Pharmaceuticals, Inc.
INO
CFO
20,000
0.0126%
$10.69$213,706-21.7%
2020-07-15SaleInovio Pharmaceuticals, Inc.
INO
CFO
35,000
0.0215%
$24.95$873,208-57.61%
2020-06-30SaleInovio Pharmaceuticals, Inc.
INO
CFO
35,000
0.0208%
$26.50$927,500-60.95%
2018-11-29SaleInovio Pharmaceuticals, Inc.
INO
CFO
10,001
0.0101%
$5.28$52,805-43.74%
2018-07-10SaleInovio Pharmaceuticals, Inc.
INO
CFO
10,000
0.0108%
$4.45$44,500-2.93%
2018-07-09SaleInovio Pharmaceuticals, Inc.
INO
CFO
25,000
0.0269%
$4.43$110,750-3.14%
2014-10-09PurchaseInovio Pharmaceuticals, Inc.
INO
CFO
3,960
0.0065%
$10.10$39,996-17.34%
2012-06-05PurchaseInovio Pharmaceuticals, Inc.
INO
CFO
25,000
0.019%
$0.41$10,250+42.5%
2011-10-05PurchaseInovio Pharmaceuticals, Inc.
INO
CFO
18,000
0.013%
$0.54$9,6300%
2011-10-04PurchaseInovio Pharmaceuticals, Inc.
INO
CFO
19,150
0.0142%
$0.50$9,604+10%
2011-06-24PurchaseInovio Pharmaceuticals, Inc.
INO
CFO
24,000
0.0175%
$0.57$13,622+1.69%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.